Cardiac Implants Market Highlights

Within the medical device industry, the Cardiac Implants Market serves a critical role in providing life-saving solutions for individuals with cardiovascular conditions. Heart implants, a key component of this market, encompass a wide range of devices designed to support and enhance cardiac function. These implants may include pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and implantable loop recorders, among others. Heart implants are surgically implanted or placed through minimally invasive procedures to help regulate heart rhythm, prevent arrhythmias, and monitor cardiac activity. By offering innovative and reliable solutions, heart implants play a crucial role in managing cardiovascular diseases and improving patient outcomes.

The global cardiac implants market is expected to register a CAGR of 6.30% between 2022-2030 and is anticipated to reach USD 24.83 Billion by 2030. 

Segment analysis

The global cardiac implants market has been segmented into cardiac rhythm management devices, coronary stents, prosthetic heart valve devices, ventricular assist devices, coronary stents, implantable loop recorder/implantable cardiac monitor, and others. By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others. On the basis of end-user, the market has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others.  The cardiac care centers accounted for a market value of USD 5,954.8 in 2017.

Regional Analysis

Geographically, the Americas is expected to dominate the global cardiac implants market. In this region, the rising prevalence of cardiac diseases and high adoption rates of cardiac implantable electronic devices has led to the growth of the market. In Europe, the cardiac implants market is anticipated to grow owing to the factors such as rising funding from the government for the healthcare sector and growing initiatives for heart patients by insurance companies in the region. Additionally, the rising prevalence of several heart diseases in the region has led to the increase in adoption of cardiac implants. In Europe, Italy accounted for a market share of 9.9% in the year 2017. The Asia-Pacific region is expected to be the fastest growing market for cardiac implants. Factors such as the growing geriatric population, changing lifestyle, and the rising trend of medical tourism in the Asia-Pacific region are expected to drive the market. Furthermore, the Middle East and Africa accounts for the lowest share of the global market due to the presence of poor and slow developing countries, majorly, in the African region.

Top Key Players

Market Research Future (MRFR) recognizes the following companies as the key cardiac implants market players that includes Abbott (US), Amg International (Germany), Edwards Lifesciences Corporation (US), B. Braun Melsungen AG (Germany), Biotronik (US), Boston Scientific Corporation (US), LivaNova PLC (UK), Medtronic Plc (US), SynCardia Systems, Inc. (Arizona), and Terumo Corporation (Japan).

Key Findings of the Study:

• Global cardiac implants market is projected to reach USD 24.83 Billion by 2030 with 6.30% CAGR during the review period of 2022 to 2030.
• Americas accounted for the largest share in the region due to the high adoption rate of cardiac implants and the growing prevalence of cardiac diseases.
• The hospital segment is accounted for the largest share.
• Some of the players operating in the cardiac implants market include Abbott, Amg International, Edwards Lifesciences Corporation, and B. Braun Melsungen AG, among others.

For more information visit at MarketResearchFuture